跳至主要内容
临床试验/ISRCTN66872125
ISRCTN66872125已完成不适用

Multi-centre EuRopean study of MAjor Infectious Disease Syndromes (MERMAIDS): community-acquired sepsis-like syndrome and paediatric acute respiratory tract infection in childhood

Fondazione PENTA Onlus0 个研究点目标入组 1,000 人开始时间: 2016年8月30日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • The study will recruit into three groups (SLS, ARI and controls), each with different inclusion criteria.
  • SLS Group Cases:
  • 1. Age <6 months old on the day of admission (day 0) into the study
  • 2. Onset of symptoms within 7 days
  • 3. The attending physician has decided that the infant requires hospitalisation
  • 4. Temperature =38°C or <36°C measured by any method
  • 5. Informed consent collected on admission or within 48 hours available from guardian/carer
  • AND at least TWO of the below (with at least ONE of either 1 or 2):
  • 1. Signs of cardiovascular dysfunction: age-related tachycardia or bradychardia or hypotension or need for =40 ml/kg fluid resuscitation in first hour after presentation to hospital on day of recruitment
  • 2. Signs of respiratory dysfunction: age-related tachypnoea or brady/apnoea or decreased oxygen saturation (<92% in room air)
  • 3. Skin signs: mottled skin appearance or non-blanching rash or central CRT >2 seconds
  • 4. Neurological signs: irritability, hypotonia, lethargy or an AVPU score V or below
  • ARI Group Cases:
  • 1. Age <6 years old on the day of admission (day 0) into the study
  • 2. Clinical suspicion of a new episode of acute respiratory tract illness within the last 7 days
  • 3. The attending physician has decided that the child requires hospitalisation
  • 4. Primary reason for hospital admission is clinical suspicion of a new episode of ARI
  • 5. Temperature =38°C measured by any method
  • 6. Informed consent collected on admission or within 48 hours available from guardian/carer
  • AND at least TWO of the below (with at least ONE of 1 or 2):
  • 1. Signs of lower respiratory tract infection: cough, abnormal sounds on chest auscultation (crackles, reduced breath sounds, bronchial breathing, wheezing), dyspnoea (chest indrawing, nasal flaring, grunting)
  • 2. Signs of upper respiratory tract infection: coryza, nasal congestion, sore throat, pharyngitis, myringitis, acute otitis media
  • 3. Signs of respiratory dysfunction: age-related tachypnoea or brady/apnoea or decreased oxygen saturation (<92% in room air)
  • 4. Signs of reduced general state: poor feeding, vomiting, lethargy/drowsiness
  • 1. Age < 6 years old on the day of enrolment into the study
  • 2. Afebrile on the day of enrolment
  • 3. No evidence of severe infection as judged by attending physician
  • 4. Informed consent available from guardian/carer
  • Controls aged < 6 months old will be shared between both groups. Controls should be matched to cases stratified by five age groups (0-3 months, 4-6 months, 7-11 months, 12 months-2 years and 3-5 years) and season (three-monthly intervals starting with January-March). They may be selected from the following patient groups:
  • 1. Attending for an elective or semi-elective procedure requiring general anaesthesia or moderate-deep sedation
  • (including e.g. surgery, radiological examinations etc)
  • 2. Well and otherwise healthy children attending outpatient clinic for a non-emergency clinical assessment for which a blood test is indicated as part of routine clinical care

排除标准

  • The study will recruit into three groups (SLS, ARI and case-controls), each with different exclusion criteria.
  • SLS Group Cases:
  • 1. In-patient care for 24 hours or more for any condition within the previous 30 days, except for routine postnatal care
  • 2. Aetiology other than infection (such as trauma, autoimmune disorder, malignancy) is suspected to be the primary cause of the current illness episode
  • 3. Any signs and symptoms suggesting a clear primary focus of infection, such as pneumonia, urinary/kidney infection, open wounds, indwelling catheters, re-activation of previously diagnosed infectious or inflammatory condition
  • 4. Dehydration due to previous illness episode such as diarrhoea and vomiting
  • 5. Immunocompromised infant (stem cell transplant, solid organ transplant, HIV, AIDS, immunosuppressive therapy, inherited or congenital immunodeficiency, haemodialysis)
  • 6. Presence of complex chronic comorbidities
  • 7. Body weight <3kg on day of assessment and/or corrected gestational age <37 weeks
  • ARI Group Cases:
  • 1. In-patient care for 24 hours or more for any condition within the previous 30 days, except for routine postnatal care
  • 2. Aetiology other than infection (such as trauma, autoimmune disorder, malignancy) is suspected to be the primary cause of the current illness episode
  • 3. Any signs and symptoms suggesting a clear primary focus of infection, such as urinary/kidney infection, open
  • wounds, indwelling catheters, re-activation of previously diagnosed infectious or inflammatory condition
  • 4. Dehydration due to previous illness episode such as diarrhoea and vomiting
  • 5. Immunocompromised infant (stem cell transplant, solid organ transplant, HIV, AIDS, immunosuppressive therapy, inherited or congenital immunodeficiency, haemodialysis)
  • 6. Presence of complex chronic comorbidities
  • 7. Body weight <3 kg on day of assessment and/or corrected gestational age <37 weeks
  • 1. In-patient care for 24 hours or more for any condition within the previous 30 days except for routine postnatal care or current planned hospitalisation/procedure
  • 2. Temperature =38.5°C or <36°C
  • 3. Immunocompromised infant (stem cell transplant, solid organ transplant, HIV, AIDS, immunosuppressive therapy, inherited or congenital immunodeficiency, haemodialysis)
  • 4. Presence of complex chronic comorbidities
  • 5. Body weight <3kg on day of assessment and/or corrected gestational age <37 weeks

研究者

相似试验